High Performance Liquid Chromatography-tandem Mass Spectrometry (HPLC/MS/MS) Assay for Chiral Separation of Lactic Acid Enantiomers in Urine Using a Teicoplanin Based Stationary Phase
Overview
Chemistry
Affiliations
A novel method for the separation and simultaneous determination of urinary D- and L-lactic acid enantiomers by high performance liquid chromatography-tandem mass spectrometry (HPLC/MS/MS) is presented. The chiral separation was optimized on a Chirobiotic teicoplanin aglyocone (TAG) column. Most interestingly, the addition of water in small volume fraction to the polar organic mobile phase was found to significantly improve the chromatography. Calibration curves were linear (r2>0.9950) over the range 3-1000 mg/L for L-lactic acid and 0.5-160.8 mg/L for D-lactic acid. The limit of detection (LOD) (S/N=3) and limit of quantification (LOQ) (S/N=10) were determined experimentally (n=3) to be 0.2 and 0.5mg/L for L-lactic acid and 0.4 and 1.3 mg/L for D-lactic acid, respectively. The normal patient range of L-lactic acid was 1-20 microg/mg creatinine with an elevated value of 85 microg/mg creatinine. For D-lactic acid, the range of normal values were between 0 and 5 microg/mg creatinine with an elevated value of 40 microg/mg creatinine. Finally, the validated method allows for rapid analysis with a total run time of 7.5 min.
Liu Z, Williams S, Jacobs J, Neachtain A, Rochfort S Molecules. 2024; 29(6).
PMID: 38543032 PMC: 10975154. DOI: 10.3390/molecules29061398.
Perinelli D, Cambriani A, Antognini G, Agostinacchio G, Marliani A, Cespi M Biomedicines. 2023; 11(9).
PMID: 37760935 PMC: 10525989. DOI: 10.3390/biomedicines11092493.
In Vitro Animal Model for Estimating the Time since Death with Attention to Early Postmortem Stage.
Szeremeta M, Samczuk P, Pietrowska K, Kowalczyk T, Przeslaw K, Sieminska J Metabolites. 2023; 13(1).
PMID: 36676951 PMC: 9861157. DOI: 10.3390/metabo13010026.
Ma Z, Fang L, Ungerfeld E, Li X, Zhou C, Tan Z Antioxidants (Basel). 2022; 11(3).
PMID: 35326119 PMC: 8944473. DOI: 10.3390/antiox11030469.
Enantioselectivity Effects in Clinical Metabolomics and Lipidomics.
Oliveira R, Simionato A, Cass Q Molecules. 2021; 26(17).
PMID: 34500665 PMC: 8433918. DOI: 10.3390/molecules26175231.